Deal activity is likely to remain elevated in the healthcare and life sciences sectors in 2021, although there will be winners and losers when it comes to valuations, according to a new KPMG survey of almost 300 industry executives and investors. Here are 10 key takeaways from KPMG’s findings, per Modern Healthcare.
Read the full article: KPMG Says Deal Activity Will Stay High in ’21: 10 Takeaways //
Source: https://www.modernhealthcare.com/finance/kpmg-says-deal-activity-will-stay-high-21-10-takeaways